MoonLake Immunotherapeutics
IPOMoonlake TX Immunotherapeutics
Public · Zug, Switzerland · Founded 2021
- Headquarters
- Zug
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- moonlaketx.com
- Last Round
- Series AOct 2021
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company using Nanobody technology to develop next-level therapies for immunologic diseases.
Summary
MoonLake Immunotherapeutics is a Biotech company based in Zug, Switzerland, founded in 2021. Its most recent funding was a Series A round in Oct 2021. Investors include Hercules Capital, Helix Acquisition Corp. and Cormorant Asset Management.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...